Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription

Published:2015-02 Issue:2 Volume:25 Page:60-72
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Kapoor Ritika,Martinez-Vega Rosario,Dong Di,Tan Sharlene Yanying,Leo Yee-Sin,Lee Cheng-Chuan,Sung Cynthia,Ng Oon-Tek,Archuleta Sophia,Teo Yik-Ying

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference18 articles.

1. The abacavir hypersensitivity reaction: a review.;Clay;Clin Ther,2002

2. . Abacavirlamivudine versus tenofovir DFemtricitabine as part of combination regimens for initial treatment of HIV: final results.;Sax;J Infect Dis,2011

3. . Comparison of abacavirlamivudine and tenofoviremtricitabine among treatment-naive HIV-infected patients initiating therapy.;Tan;J Acquir Immune Defic Syndr,2011

4. Abacavir hypersensitivity reaction.;Hewitt;Clin Infect Dis,2002

5. . Association between presence of HLA-B5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.;Mallal;Lancet,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV;Pharmacogenomics;2023-09-28

2. Development of an Isothermal Point-of-care Genetic Rapid Test for the Detection of the HLA-B*57:01 Allele, a Predictor for Hypersensitivity Reaction Caused by Abacavir, for Stratifying Patients for Antiretroviral Abacavir HIV Therapy;Current Pharmacogenomics and Personalized Medicine;2023-04

3. Economic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions;Economic Evaluation in Genomic and Precision Medicine;2023

4. Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guidelines: A Systematic Review;Clinical Pharmacology & Therapeutics;2022-10-09

5. Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV;ClinicoEconomics and Outcomes Research;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3